Analysts expect DENTSPLY SIRONA Inc (NASDAQ:XRAY) to post $0.51 earnings per share for the current fiscal quarter, according to Zacks. Seven analysts have issued estimates for DENTSPLY SIRONA’s earnings, with the highest EPS estimate coming in at $0.58 and the lowest estimate coming in at $0.48. DENTSPLY SIRONA posted earnings of $0.69 per share during the same quarter last year, which suggests a negative year over year growth rate of 26.1%. The business is scheduled to issue its next quarterly earnings results on Friday, May 5th.
On average, analysts expect that DENTSPLY SIRONA will report full year earnings of $2.85 per share for the current year, with EPS estimates ranging from $2.80 to $2.88. For the next fiscal year, analysts expect that the business will post earnings of $3.23 per share, with EPS estimates ranging from $3.10 to $3.32. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that cover DENTSPLY SIRONA.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Friday, February 17th. The medical instruments supplier reported $0.67 earnings per share for the quarter, topping analysts’ consensus estimates of $0.65 by $0.02. DENTSPLY SIRONA had a return on equity of 8.04% and a net margin of 11.15%. The business had revenue of $996.50 million for the quarter, compared to analyst estimates of $1.02 billion. During the same quarter last year, the firm posted $0.65 earnings per share. The business’s revenue was up 48.5% compared to the same quarter last year.
Several analysts recently commented on XRAY shares. Zacks Investment Research cut DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Monday, January 9th. Stifel Nicolaus upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating and boosted their price target for the stock from $62.00 to $70.00 in a research report on Monday, February 13th. Barrington Research cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Tuesday, February 21st. Finally, Jefferies Group LLC dropped their price target on DENTSPLY SIRONA from $70.00 to $68.00 and set a “buy” rating for the company in a research report on Monday, January 23rd. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $67.75.
TRADEMARK VIOLATION WARNING: This piece was published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://sportsperspectives.com/2017/05/20/zacks-brokerages-expect-dentsply-sirona-inc-xray-will-announce-earnings-of-0-51-per-share-updated-updated.html.
In other DENTSPLY SIRONA news, insider Bret W. Wise sold 146,900 shares of the business’s stock in a transaction on Wednesday, March 1st. The stock was sold at an average price of $64.17, for a total transaction of $9,426,573.00. Following the transaction, the insider now owns 142,121 shares of the company’s stock, valued at $9,119,904.57. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Ulrich Michel sold 24,000 shares of the business’s stock in a transaction on Thursday, March 9th. The stock was sold at an average price of $62.84, for a total value of $1,508,160.00. Following the transaction, the insider now directly owns 94,067 shares in the company, valued at approximately $5,911,170.28. The disclosure for this sale can be found here. Insiders have sold 405,854 shares of company stock worth $25,560,435 in the last three months. 2.20% of the stock is currently owned by corporate insiders.
A number of institutional investors have recently added to or reduced their stakes in XRAY. Price T Rowe Associates Inc. MD raised its position in DENTSPLY SIRONA by 6.4% in the third quarter. Price T Rowe Associates Inc. MD now owns 14,126,303 shares of the medical instruments supplier’s stock worth $839,526,000 after buying an additional 850,914 shares during the period. Ruane Cunniff & Goldfarb Inc. raised its position in DENTSPLY SIRONA by 11.5% in the fourth quarter. Ruane Cunniff & Goldfarb Inc. now owns 9,102,714 shares of the medical instruments supplier’s stock worth $525,500,000 after buying an additional 939,312 shares during the period. Atlanta Capital Management Co. L L C raised its position in DENTSPLY SIRONA by 1.1% in the fourth quarter. Atlanta Capital Management Co. L L C now owns 5,462,276 shares of the medical instruments supplier’s stock worth $315,337,000 after buying an additional 59,853 shares during the period. Veritas Asset Management LLP raised its position in DENTSPLY SIRONA by 2.1% in the third quarter. Veritas Asset Management LLP now owns 5,432,428 shares of the medical instruments supplier’s stock worth $322,849,000 after buying an additional 109,722 shares during the period. Finally, Bessemer Group Inc. raised its position in DENTSPLY SIRONA by 0.4% in the fourth quarter. Bessemer Group Inc. now owns 2,636,408 shares of the medical instruments supplier’s stock worth $152,200,000 after buying an additional 10,371 shares during the period. 94.32% of the stock is currently owned by institutional investors.
DENTSPLY SIRONA (NASDAQ:XRAY) traded down 0.36% during mid-day trading on Thursday, reaching $63.24. The company’s stock had a trading volume of 1,118,338 shares. DENTSPLY SIRONA has a 12-month low of $55.00 and a 12-month high of $65.83. The firm’s 50 day moving average price is $62.75 and its 200 day moving average price is $60.06. The stock has a market cap of $14.52 billion, a price-to-earnings ratio of 32.60 and a beta of 1.21.
The business also recently disclosed a quarterly dividend, which was paid on Thursday, April 13th. Shareholders of record on Friday, March 31st were paid a dividend of $0.0875 per share. The ex-dividend date was Wednesday, March 29th. This represents a $0.35 dividend on an annualized basis and a yield of 0.55%. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.08. DENTSPLY SIRONA’s payout ratio is 15.98%.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for DENTSPLY SIRONA Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc and related companies with MarketBeat.com's FREE daily email newsletter.